We are live on ! Find out more
THP

Tower House Partners Portfolio holdings

AUM $16.8M
1-Year Est. Return 41.98%
This Fund
S&P 500
This Quarter Est. Return
-13.25%
1 Year Est. Return
-41.98%
3 Year Est. Return
+21.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136M
AUM Growth
-$4.72M
Cap. Flow
+$14.6M
Cap. Flow %
10.77%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$46.4M
2
AZTA icon
Azenta
AZTA
+$14.6M

Top Sells

Rank Stock Value
1
OLLI icon
Ollie's Bargain Outlet
OLLI
+$35.9M
2
BIO icon
Bio-Rad Laboratories Class A
BIO
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIO icon
1
Bio-Rad Laboratories Class A
BIO
$8.15B
$47.3M 34.87%
135,000
-28,379
-17% -$10.4M
AZTA icon
2
Azenta
AZTA
$1.21B
$44.2M 32.59%
1,450,000
+400,000
+38% +$14.6M
CTLT
3
DELISTED
CATALENT, INC.
CTLT
$44.2M 32.54%
+850,000
New +$46.4M
OLLI icon
4
Ollie's Bargain Outlet
OLLI
$4.02B
– –
-550,000
Closed -$35.9M

Similar funds

RCGV
Ribbit Capital GP V Palo Alto, California $19.8M AUM
SCM
Stamina Capital Management New York $13.3M AUM 71.17% 1-Year Est. Return
CCA
Cross Creek Advisors Salt Lake City, Utah $20.5M AUM 54.22% 1-Year Est. Return
OHU
Odey Holdings (UK) London, United Kingdom $12.4M AUM 20.7% 1-Year Est. Return
OA
Oakhurst Advisors Los Angeles, California $21.3M AUM 8.8% 1-Year Est. Return
JM
Jeneq Management New York $22.3M AUM 47.87% 1-Year Est. Return
OP
Osmium Partners Greenbrae, California $10.4M AUM 73.79% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return

Tower House Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Tower House Partners held 4 positions worth $136M, down 3.4% from $140M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tower House Partners deployed $14.6M of net new capital in Q1 2020, opening 1 new position and adding to 1 existing holding. Its largest new stake was CATALENT, INC.: 850,000 shares worth $44.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 74% a quarter earlier, followed by Consumer Staples.

On the sell side, the largest reduction was Bio-Rad Laboratories Class A, an estimated $10.4M trimmed.

  • Tower House Partners's largest Q1 2020 buy was CATALENT, INC.: 850,000 shares worth $44.2M.
  • Tower House Partners added most to Azenta in Q1 2020, an estimated $14.6M increase.
  • Tower House Partners's biggest Q1 2020 reduction was Bio-Rad Laboratories Class A, cutting an estimated $10.4M.
  • Tower House Partners fully exited Ollie's Bargain Outlet in Q1 2020, selling an estimated $35.9M.
  • Tower House Partners's ten largest holdings make up 100% of its $136M portfolio in Q1 2020.
  • Tower House Partners opened 1 new position and closed 1 in Q1 2020.
  • Tower House Partners's portfolio value fell 3.4% quarter-over-quarter to $136M.

Based on Tower House Partners's 13F filing for Q1 2020, filed 4 Jun 2020.